GF New Dev and TFM GFAN mtg Feb 2012

Download Report

Transcript GF New Dev and TFM GFAN mtg Feb 2012

Global Fund New
Developments
Global Fund Reforms
Transformation Funding Mechanism, Bridge
Funding, 2 stage funding process,
Principle Results (2004-2011)
0
Source: Global Fund Grant Data
January 2012
GP/021209/9
Evolution of Funding (2002-2010)
2002-2013
# of
grants
12
Annual disbursement
$ US billion
10
Projected annual
disbursement
Number of signed grants
8
$11.7
billion
pledged
$9.4 billion
contributed
800
600
6
$6.2 billion
contributed
4
2
400
$3.4 billion
$3.4 billion
contribute
contributed
d
2002 - 2004
200
2005 - 2007
2008 - 2010
2011 - 2013
Reforming The Global Fund
• Shift from emergency response to sustainability and
fiduciary responsibility
• Status quo insufficient
• Maintain donor confidence
• All want better risk management ; safeguarding of
resources; more efficient operations; value for
money
Donors are linking commitments to concrete results on reforms
2
Overview TFM
•
Targeted funding opportunity to focus limited resources on critical protection of
gains achieved in the fight against the three diseases as a transition to the new
Strategy
Eligibility
Proposal scope
Review and
approval
process
•
In principle ECFP applies (e.g. Counterpart Financing, Targeted Pool,
prioritization etc.)
•
2-year funding request
•
Limited to continuation, and no scale-up
•
Essential/critical services
•
Request of relevant HSS support- only through embedding in disease
proposals (no separate HSS component)
•
NSA funding requests based on same scope
•
Materials available 12 December 2011
•
Submission deadline 31 March 2012
•
TRP meeting during second quarter 2012 and intermediate Board endorsement
•
Grant negotiation schedule determined by program needs/prioritization measures
•
Rolling Board approval and grant start dates
1
Access to new funding over time
2011
2012
2013
2014
“New Funding Model/Opportunity”
“The new
strategy”
Development of the new funding
model/opportunity as part of
Strategy implementation
Application & Review
(including iteration)
Global demand/gap
assessment
(work with countries)
Mid-term
replenishment
Alternative to
Round 11:
“Transitional
Funding”
“Transitional Funding Mechanism (TFM)”
Application & Review
Funding
Funding
Transformation Funding Mechanism
• Replace Round 11 with a new “Transitional Funding
Mechanism” - to provide continuation of essential
prevention, treatment and/or care services to existing
grantees
• Process will involve a tailored application and an iterative
review process to ensure high impact and strategic
investments
• Develop new business model to enable funding from 2014,
based on principles of the new GF 2012-2016 Strategy
Transitional Funding Mechanism
• The Global Fund Board decided to replace Round 11
with the Transitional Funding Mechanism due to
inadequate resources
– protect the gains achieved (e.g. interventions whose
interruption would mean a significant rebound in
transmission); and
– save lives; and
– are high impact, evidence-based, targeted to most
appropriate populations and represent good value for
money in a resource-constrained environment
Eg. Essential Services –HIV and AIDS
•
•
•
•
antiretroviral therapy
TB screening and treatment among PLWHA
PMTCT
Prevention and treatment targeted at key populations
with high levels of incidence (including evidence-based
programs reaching men who have sex with men,
people who inject drugs, prisoners and sex workers)
• Male circumcision where indicated (i.e. in settings with
high prevalence and low rates of male circumcision).
Eg Not Likely to be Funded in TFM
• scale up of antiretroviral therapy,
• untargeted population approaches to HIV prevention
(including mass media campaigns), general population
HIV testing in concentrated epidemics, generalized
nutritional support, blood safety, universal
precautions, pre-exposure prophylaxis, infrastructure
development, procurement of vehicles, and
generalized/untargeted trainings.
2
Review and approval process
Revised
guidance to
applicants
Application
Screening
TRP
review
Endorsed
by
Board/SIIC
and initial
assessment
of supply +
demand
Grant negotiation
Rolling Board Approval
(finalize negotiation +
grant signing)
More iterative
clarification phase
When
12 Dec
2011
31 Mar
2012
May
2012
June
2012
July
2012
From Aug 2012/2013
on a rolling basis
TRP review to:
•
Assess the technical merit in accordance with existing review criteria
•
Determine whether applicants have demonstrated a risk of disruption of
essential prevention, treatment and/or care services; and
•
Assess whether the activities for which funding is sought cannot be funded by
alternate sources of funding.
2
Bridge Funding Mechanism implications
Policy area
Changes
Scope
• Bridge Funding will continue existing program at the same scale
• “Essential treatment, prevention and care services” are not yet
clearly defined and will be determined by the TRP
Eligible Grants
• Grants to expire between 31 December 2011 and 31 December 2012
• If TFM funding becomes available prior to BFM end date, the bridge
funding amount will be adjusted to avoid duplicative financing
Reimbursement
• Relevant costs should be reimbursed if the corresponding request is
approved
• If not, reduced from the existing cash balance of the PR
Performance Based
Funding
• Performance of the grant should be factored in deciding the funding
amount of BFM
Priority of Funding
• Priority of bridge funding is the same with that of TFM
• Lower priority than CoS, Renewals, and Round 10 funding needs
12
Phase 2 review process
Phase 2 serves as a checkpoint to ensure that funding is performancebased and that programming is aligned with epidemiological evidence
Global Fund and
PR(s) sign Grant
Agreement(s)
Program month
PR implementation
and reporting; CCM
oversight; LFA
verifications; Global
Fund performancebased disbursements;
18
partner support
CCM
submits
Request for
Continued
Funding
21
LFA
Phase 2
Assessment
Report
due
22
Secretariat
Phase 2
recommendation to the
Board 1st day
Month 24
23
24
Negotiate and
sign extension to
the Grant
Agreement(s) by
Month 27
27
1
Board
approves
Proposals
PR(s) receives first
disbursement;
Program start date
CCM can
accelerate timing
CCM invited
to submit a
Request for
Continued
Funding on
the last day of
Month 18
Phase 2
Panel
meeting
Board
Phase 2
approval disbursement
10th of
Month 24
Phase 2 Renewal Process
* End of months
2
Key modifications to renewals
ECFP
Policy & Process
55% Rule
•
G-20 UMIs no longer eligible for renewals unless
have “extreme” disease burden
•
Grants made ineligible will receive transition funding
if renewal scheduled for 2012
•
Counterpart Financing and Focus of Proposal
requirements apply
•
Review of composition and role of Grant Renewals
Panel and involvement of TRP
•
Revisit reprogramming policy and processes
•
Revisit role of Country Team members and technical
partners in developing CCM Request for Renewal
•
Develop guidance for countries and CTs: defining an
‘iterative process’
•
Funding for LICs must be at least 55% of portfolio
distribution in any given funding opportunity
2
Impact of ECFP on countries by income levels
Income
Level
Low Income
Countries
Lower-Low
Income
Countries
Upper-Low
Income
Countries
Upper-Middle
Income
Countries (nonG20)
Upper-Middle
Income
Countries (G20)
Focus of
Renewal
Counterpart
Financing
Review + PBF
adjustments
No Restrictions
Not applicable
5% minimum
threshold
Incremental
Amount +
Staggered
Commitments
No Restrictions
50% focus on
special groups
and/or
interventions
20% minimum
threshold
Incremental
Amount +
Staggered
Commitments
No Restrictions
50% focus on
special groups
and/or
interventions
40% minimum
threshold
Incremental
Amount +
Staggered
Commitments
No Restrictions
100% focus on
special groups
and/or
interventions
60% minimum
threshold
Incremental
Amount +
Staggered
Commitments
Extreme disease
burden
100% focus on
special groups
and/or
interventions
60% minimum
threshold
Incremental
Amount +
Staggered
Commitments
Disease Burden
15
Challenges
•
•
•
•
•
•
•
TFM/Bridge Funding
Prioritizing country to support
Reduced Resources in certain regions
Tracking Co-financing
Global fund fatigue—too complicate, OIG
Evidence, value for money,
Reprogramming
Opportunities
• Risk Management framework
• Iterative funding process
– Regional proposals
– Role of CS
•
•
•
•
Country ownership consultation
Research to build the case—CSS, VfM, NSP
Development of Human Rights Framework
Emergency Donor conf—MTR